<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04909931</url>
  </required_header>
  <id_info>
    <org_study_id>64012</org_study_id>
    <nct_id>NCT04909931</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation on Outcome and Disease Activity.</brief_title>
  <official_title>Vitamin D Supplementation on Outcome and Disease Activity in Rheumatoid Arthritis Patients at Rajavithi Hospital : A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study efficacy of Vitamin D on outcome and disease activity ; DAS28-ESR in Rheumatoid&#xD;
      arthritis patients at Rajavithi hospital .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To study efficacy of vitamin D on disease activity RA patients at Rajavithi hospital</measure>
    <time_frame>12 weeks</time_frame>
    <description>Determine disease activity by DAS28-ESR in relation with vitamin D supplementation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To study efficacy of vitamin D on IL-6 in RA patients at Rajavithi hospital</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR</condition>
  <arm_group>
    <arm_group_label>vitamin D supplementation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First arm ; add on vitamin D 40,000 IU/week for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>second arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>add on placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D 2</intervention_name>
    <description>Randomized allocation first arm : add on vitamin D supplementation 40,000 iu/week for 12 weeks</description>
    <arm_group_label>vitamin D supplementation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Second arm : add on placebo for 12 weeks</description>
    <arm_group_label>second arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 yrs old&#xD;
&#xD;
          -  RA diagnosed by ACR/EULAR 2010&#xD;
&#xD;
          -  low to moderate disease activity&#xD;
&#xD;
          -  on stable NSAIDs and DMARDs for at least 1 month&#xD;
&#xD;
          -  Received Prednisolone less than or equal to 7.5 mg/day&#xD;
&#xD;
          -  serum calcium, phosphorus and ALP are within normal limit.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney disease stage 3 or higher&#xD;
&#xD;
          -  History of TB&#xD;
&#xD;
          -  History of Chronic liver disease&#xD;
&#xD;
          -  Pregnancy or breast-feeding&#xD;
&#xD;
          -  adjustment of immuno-suppressive drugs, steroid&#xD;
&#xD;
          -  other connective tissue disease&#xD;
&#xD;
          -  Vitamin D allergy&#xD;
&#xD;
          -  received other drugs which have vitamin D component&#xD;
&#xD;
          -  serum Vitamin D less than 10 ng/mL&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sirilak Nunthiyakul, Medicine</last_name>
    <role>Study Chair</role>
    <affiliation>Rajavithi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sirilak Nunthiyakul, Medicine</last_name>
    <phone>0832973597</phone>
    <email>Dearly_medicine_143@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kittiwan Sumethkul, Rheumato</last_name>
    <phone>0896658160</phone>
    <email>ckittiwan@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rajavithi hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sirilak Nunthiyakul, Medicine</last_name>
      <phone>0832973597</phone>
      <email>Dearly_medicine_143@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Kittiwan Sumethkul, rheumato</last_name>
      <phone>0896658160</phone>
      <email>ckittiwan@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Polasik K, Piotrowska E, Lipi≈Ñska B, Witkowski JM, Bryl E, Tukaj S. Vitamin D status in patients with rheumatoid arthritis: a correlation analysis with disease activity and progression, as well as serum IL-6 levels. Acta Biochim Pol. 2017;64(4):667-670. doi: 10.18388/abp.2017_1636. Epub 2017 Dec 5.</citation>
    <PMID>29202486</PMID>
  </reference>
  <reference>
    <citation>Gopal K, Thevarajah M, Ng CM, Raja J. Effects of vitamin D on disease activity and serum interleukin-6 in rheumatoid arthritis. Int J Rheum Dis. 2019 May;22(5):834-841. doi: 10.1111/1756-185X.13484. Epub 2019 Feb 6.</citation>
    <PMID>30729713</PMID>
  </reference>
  <reference>
    <citation>Aslam MM, John P, Bhatti A, Jahangir S, Kamboh MI. Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response. Biomed Res Int. 2019 May 7;2019:3494937. doi: 10.1155/2019/3494937. eCollection 2019. Review.</citation>
    <PMID>31205940</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

